IL9 and non-small cell lung carcinoma: It was discovered that miR-208b-5p inactivates epithelial-mesenchymal transition (EMT) by targeting the IL-9/STAT3 pathway and reducing the migration and invasion of non-small cell lung cancer (NSCLC) cells (Ma et al., 2020).